Outcomes of curative-intent radiotherapy in non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD)
Author:
Funder
Elekta
Pfizer
Manchester Biomedical Research Centre
AstraZeneca
Cancer Research UK
University of Manchester
Cancer Research UK Manchester Centre
Roche
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference40 articles.
1. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history;Young;European Respiratory Journal,2008
2. Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research;Punturieri;JNCI,2009
3. Longitudinal health-related quality of life among individuals considering treatment for stage i non-small-cell lung cancer;Nugent;Ann Am Thorac Soc,2020
4. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer;Loganathan;Chest,2006
5. Lung cancer and interstitial lung disease: A literature review;Naccache;J Thorac Dis. AME Publishing Company,2018
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and Safety of Immune Checkpoint Inhibitors Combined with Iodine-125 Seed Implantation in Driver-Gene-NSCLC: A Retrospective Study;2024-05-30
2. Modulation of T Cell Differentiation in Mice with COPD Combined with Lung Cancer Through Key Targets of PD-1 by Tao Hong Si Wu Tang;Applied Biochemistry and Biotechnology;2024-03-15
3. The preventative effects of statin on lung cancer development in patients with idiopathic pulmonary fibrosis using the National Health Insurance Service Database in Korea;PLOS ONE;2024-03-13
4. Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity;Cancer Treatment Reviews;2024-03
5. Quantification of diffuse parenchymal lung disease in non‐small cell lung cancer patients with definitive concurrent chemoradiation therapy for predicting radiation pneumonitis;Thoracic Cancer;2023-11-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3